Trial Profile
A Single-centre, Randomised single-blind, placebo- and active-controlled, 4-period crossover study to evaluate the pharmacodynamic effects of Alicapistat on sleep parameters in Healthy Men
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Aug 2018
Price :
$35
*
At a glance
- Drugs Alicapistat (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions; Pharmacodynamics
- 21 Aug 2018 New trial record